Pharma & Healthcare
Global Colloids (Blood Plasma) Market Research Report 2026
- Jan 17, 26
- ID: 688119
- Pages: 143
- Figures: 144
- Views: 4
This report delivers a comprehensive overview of the global Colloids (Blood Plasma) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Colloids (Blood Plasma). The Colloids (Blood Plasma) market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Colloids (Blood Plasma) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Colloids (Blood Plasma) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Colloids (Blood Plasma) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Colloids (Blood Plasma) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Colloids (Blood Plasma) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Colloids (Blood Plasma) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Colloids (Blood Plasma) Market Overview
1.1 Product Definition
1.2 Colloids (Blood Plasma) by Type
1.2.1 Global Colloids (Blood Plasma) Market Value by Type: 2025 vs 2032
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Colloids (Blood Plasma) by Application
1.3.1 Global Colloids (Blood Plasma) Market Value by Application: 2025 vs 2032
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts
1.4.1 Global Colloids (Blood Plasma) Revenue 2021–2032
1.4.2 Global Colloids (Blood Plasma) Sales 2021–2032
1.4.3 Global Colloids (Blood Plasma) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Colloids (Blood Plasma) Market Competition by Manufacturers
2.1 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Colloids (Blood Plasma), Product Types and Applications
2.7 Global Key Manufacturers of Colloids (Blood Plasma), Date of Entry into the Industry
2.8 Global Colloids (Blood Plasma) Market Competitive Situation and Trends
2.8.1 Global Colloids (Blood Plasma) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Colloids (Blood Plasma) Players Market Share by Revenue
2.8.3 Global Colloids (Blood Plasma) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Colloids (Blood Plasma) Market Scenario by Region
3.1 Global Colloids (Blood Plasma) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Colloids (Blood Plasma) Sales by Region: 2021–2032
3.2.1 Global Colloids (Blood Plasma) Sales by Region: 2021–2026
3.2.2 Global Colloids (Blood Plasma) Sales by Region: 2027–2032
3.3 Global Colloids (Blood Plasma) Revenue by Region: 2021–2032
3.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2021–2026
3.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2027–2032
3.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country
3.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Colloids (Blood Plasma) Sales by Country (2021–2032)
3.4.3 North America Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
3.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Colloids (Blood Plasma) Sales by Country (2021–2032)
3.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Region
3.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Region (2021–2032)
3.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
3.7.1 Latin America Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Colloids (Blood Plasma) Sales by Country (2021–2032)
3.7.3 Latin America Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
3.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Colloids (Blood Plasma) Sales by Type (2021–2032)
4.1.1 Global Colloids (Blood Plasma) Sales by Type (2021–2026)
4.1.2 Global Colloids (Blood Plasma) Sales by Type (2027–2032)
4.1.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2021–2032)
4.2 Global Colloids (Blood Plasma) Revenue by Type (2021–2032)
4.2.1 Global Colloids (Blood Plasma) Revenue by Type (2021–2026)
4.2.2 Global Colloids (Blood Plasma) Revenue by Type (2027–2032)
4.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2021–2032)
4.3 Global Colloids (Blood Plasma) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Colloids (Blood Plasma) Sales by Application (2021–2032)
5.1.1 Global Colloids (Blood Plasma) Sales by Application (2021–2026)
5.1.2 Global Colloids (Blood Plasma) Sales by Application (2027–2032)
5.1.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2021–2032)
5.2 Global Colloids (Blood Plasma) Revenue by Application (2021–2032)
5.2.1 Global Colloids (Blood Plasma) Revenue by Application (2021–2026)
5.2.2 Global Colloids (Blood Plasma) Revenue by Application (2027–2032)
5.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2021–2032)
5.3 Global Colloids (Blood Plasma) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Company Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 Shanghai Raas
6.6.1 Shanghai Raas Company Information
6.6.2 Shanghai Raas Description and Business Overview
6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
6.6.5 Shanghai Raas Recent Developments/Updates
6.7 CTBB
6.7.1 CTBB Company Information
6.7.2 CTBB Description and Business Overview
6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
6.7.5 CTBB Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 Rongsheng Pharmaceutical
6.9.1 Rongsheng Pharmaceutical Company Information
6.9.2 Rongsheng Pharmaceutical Description and Business Overview
6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.9.5 Rongsheng Pharmaceutical Recent Developments/Updates
6.10 Boya Rongsheng
6.10.1 Boya Rongsheng Company Information
6.10.2 Boya Rongsheng Description and Business Overview
6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
6.10.5 Boya Rongsheng Recent Developments/Updates
6.11 B. Braun Medical
6.11.1 B. Braun Medical Company Information
6.11.2 B. Braun Medical Description and Business Overview
6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
6.11.5 B. Braun Medical Recent Developments/Updates
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Company Information
6.12.2 Fresenius Kabi Description and Business Overview
6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
6.12.5 Fresenius Kabi Recent Developments/Updates
6.13 HOSPIRA
6.13.1 HOSPIRA Company Information
6.13.2 HOSPIRA Description and Business Overview
6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
6.13.5 HOSPIRA Recent Developments/Updates
6.14 Axa parenterals
6.14.1 Axa parenterals Company Information
6.14.2 Axa parenterals Description and Business Overview
6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
6.14.5 Axa parenterals Recent Developments/Updates
6.15 Fresenius Kabi (China)
6.15.1 Fresenius Kabi (China) Company Information
6.15.2 Fresenius Kabi (China) Description and Business Overview
6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
6.15.5 Fresenius Kabi (China) Recent Developments/Updates
6.16 CR Double-Crane
6.16.1 CR Double-Crane Company Information
6.16.2 CR Double-Crane Description and Business Overview
6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
6.16.5 CR Double-Crane Recent Developments/Updates
6.17 Kelun Group
6.17.1 Kelun Group Company Information
6.17.2 Kelun Group Description and Business Overview
6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
6.17.5 Kelun Group Recent Developments/Updates
6.18 Shandong Qidu Pharmaceutical
6.18.1 Shandong Qidu Pharmaceutical Company Information
6.18.2 Shandong Qidu Pharmaceutical Description and Business Overview
6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.18.5 Shandong Qidu Pharmaceutical Recent Developments/Updates
6.19 Shandong Hualu Pharmaceutical
6.19.1 Shandong Hualu Pharmaceutical Company Information
6.19.2 Shandong Hualu Pharmaceutical Description and Business Overview
6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.19.5 Shandong Hualu Pharmaceutical Recent Developments/Updates
6.20 Minsheng Pharma
6.20.1 Minsheng Pharma Company Information
6.20.2 Minsheng Pharma Description and Business Overview
6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
6.20.5 Minsheng Pharma Recent Developments/Updates
6.21 Kanglepharm
6.21.1 Kanglepharm Company Information
6.21.2 Kanglepharm Description and Business Overview
6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
6.21.5 Kanglepharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Colloids (Blood Plasma) Industry Chain Analysis
7.2 Colloids (Blood Plasma) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Colloids (Blood Plasma) Production Mode & Process Analysis
7.4 Colloids (Blood Plasma) Sales and Marketing
7.4.1 Colloids (Blood Plasma) Sales Channels
7.4.2 Colloids (Blood Plasma) Distributors
7.5 Colloids (Blood Plasma) Customer Analysis
8 Colloids (Blood Plasma) Market Dynamics
8.1 Colloids (Blood Plasma) Industry Trends
8.2 Colloids (Blood Plasma) Market Drivers
8.3 Colloids (Blood Plasma) Market Challenges
8.4 Colloids (Blood Plasma) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Colloids (Blood Plasma) by Type
1.2.1 Global Colloids (Blood Plasma) Market Value by Type: 2025 vs 2032
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Colloids (Blood Plasma) by Application
1.3.1 Global Colloids (Blood Plasma) Market Value by Application: 2025 vs 2032
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts
1.4.1 Global Colloids (Blood Plasma) Revenue 2021–2032
1.4.2 Global Colloids (Blood Plasma) Sales 2021–2032
1.4.3 Global Colloids (Blood Plasma) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Colloids (Blood Plasma) Market Competition by Manufacturers
2.1 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Colloids (Blood Plasma), Product Types and Applications
2.7 Global Key Manufacturers of Colloids (Blood Plasma), Date of Entry into the Industry
2.8 Global Colloids (Blood Plasma) Market Competitive Situation and Trends
2.8.1 Global Colloids (Blood Plasma) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Colloids (Blood Plasma) Players Market Share by Revenue
2.8.3 Global Colloids (Blood Plasma) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Colloids (Blood Plasma) Market Scenario by Region
3.1 Global Colloids (Blood Plasma) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Colloids (Blood Plasma) Sales by Region: 2021–2032
3.2.1 Global Colloids (Blood Plasma) Sales by Region: 2021–2026
3.2.2 Global Colloids (Blood Plasma) Sales by Region: 2027–2032
3.3 Global Colloids (Blood Plasma) Revenue by Region: 2021–2032
3.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2021–2026
3.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2027–2032
3.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country
3.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Colloids (Blood Plasma) Sales by Country (2021–2032)
3.4.3 North America Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
3.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Colloids (Blood Plasma) Sales by Country (2021–2032)
3.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Region
3.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Region (2021–2032)
3.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
3.7.1 Latin America Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Colloids (Blood Plasma) Sales by Country (2021–2032)
3.7.3 Latin America Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
3.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Colloids (Blood Plasma) Sales by Type (2021–2032)
4.1.1 Global Colloids (Blood Plasma) Sales by Type (2021–2026)
4.1.2 Global Colloids (Blood Plasma) Sales by Type (2027–2032)
4.1.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2021–2032)
4.2 Global Colloids (Blood Plasma) Revenue by Type (2021–2032)
4.2.1 Global Colloids (Blood Plasma) Revenue by Type (2021–2026)
4.2.2 Global Colloids (Blood Plasma) Revenue by Type (2027–2032)
4.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2021–2032)
4.3 Global Colloids (Blood Plasma) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Colloids (Blood Plasma) Sales by Application (2021–2032)
5.1.1 Global Colloids (Blood Plasma) Sales by Application (2021–2026)
5.1.2 Global Colloids (Blood Plasma) Sales by Application (2027–2032)
5.1.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2021–2032)
5.2 Global Colloids (Blood Plasma) Revenue by Application (2021–2032)
5.2.1 Global Colloids (Blood Plasma) Revenue by Application (2021–2026)
5.2.2 Global Colloids (Blood Plasma) Revenue by Application (2027–2032)
5.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2021–2032)
5.3 Global Colloids (Blood Plasma) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Company Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 Shanghai Raas
6.6.1 Shanghai Raas Company Information
6.6.2 Shanghai Raas Description and Business Overview
6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
6.6.5 Shanghai Raas Recent Developments/Updates
6.7 CTBB
6.7.1 CTBB Company Information
6.7.2 CTBB Description and Business Overview
6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
6.7.5 CTBB Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 Rongsheng Pharmaceutical
6.9.1 Rongsheng Pharmaceutical Company Information
6.9.2 Rongsheng Pharmaceutical Description and Business Overview
6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.9.5 Rongsheng Pharmaceutical Recent Developments/Updates
6.10 Boya Rongsheng
6.10.1 Boya Rongsheng Company Information
6.10.2 Boya Rongsheng Description and Business Overview
6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
6.10.5 Boya Rongsheng Recent Developments/Updates
6.11 B. Braun Medical
6.11.1 B. Braun Medical Company Information
6.11.2 B. Braun Medical Description and Business Overview
6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
6.11.5 B. Braun Medical Recent Developments/Updates
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Company Information
6.12.2 Fresenius Kabi Description and Business Overview
6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
6.12.5 Fresenius Kabi Recent Developments/Updates
6.13 HOSPIRA
6.13.1 HOSPIRA Company Information
6.13.2 HOSPIRA Description and Business Overview
6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
6.13.5 HOSPIRA Recent Developments/Updates
6.14 Axa parenterals
6.14.1 Axa parenterals Company Information
6.14.2 Axa parenterals Description and Business Overview
6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
6.14.5 Axa parenterals Recent Developments/Updates
6.15 Fresenius Kabi (China)
6.15.1 Fresenius Kabi (China) Company Information
6.15.2 Fresenius Kabi (China) Description and Business Overview
6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
6.15.5 Fresenius Kabi (China) Recent Developments/Updates
6.16 CR Double-Crane
6.16.1 CR Double-Crane Company Information
6.16.2 CR Double-Crane Description and Business Overview
6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
6.16.5 CR Double-Crane Recent Developments/Updates
6.17 Kelun Group
6.17.1 Kelun Group Company Information
6.17.2 Kelun Group Description and Business Overview
6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
6.17.5 Kelun Group Recent Developments/Updates
6.18 Shandong Qidu Pharmaceutical
6.18.1 Shandong Qidu Pharmaceutical Company Information
6.18.2 Shandong Qidu Pharmaceutical Description and Business Overview
6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.18.5 Shandong Qidu Pharmaceutical Recent Developments/Updates
6.19 Shandong Hualu Pharmaceutical
6.19.1 Shandong Hualu Pharmaceutical Company Information
6.19.2 Shandong Hualu Pharmaceutical Description and Business Overview
6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.19.5 Shandong Hualu Pharmaceutical Recent Developments/Updates
6.20 Minsheng Pharma
6.20.1 Minsheng Pharma Company Information
6.20.2 Minsheng Pharma Description and Business Overview
6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
6.20.5 Minsheng Pharma Recent Developments/Updates
6.21 Kanglepharm
6.21.1 Kanglepharm Company Information
6.21.2 Kanglepharm Description and Business Overview
6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
6.21.5 Kanglepharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Colloids (Blood Plasma) Industry Chain Analysis
7.2 Colloids (Blood Plasma) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Colloids (Blood Plasma) Production Mode & Process Analysis
7.4 Colloids (Blood Plasma) Sales and Marketing
7.4.1 Colloids (Blood Plasma) Sales Channels
7.4.2 Colloids (Blood Plasma) Distributors
7.5 Colloids (Blood Plasma) Customer Analysis
8 Colloids (Blood Plasma) Market Dynamics
8.1 Colloids (Blood Plasma) Industry Trends
8.2 Colloids (Blood Plasma) Market Drivers
8.3 Colloids (Blood Plasma) Market Challenges
8.4 Colloids (Blood Plasma) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Colloids (Blood Plasma) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Colloids (Blood Plasma) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Colloids (Blood Plasma) Sales (MT) of Key Manufacturers (2021–2026)
Table 5. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Colloids (Blood Plasma) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Colloids (Blood Plasma), Product Types and Applications
Table 12. Global Key Manufacturers of Colloids (Blood Plasma), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Colloids (Blood Plasma) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Colloids (Blood Plasma) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Colloids (Blood Plasma) Sales by Region (MT), 2021–2026
Table 18. Global Colloids (Blood Plasma) Sales Market Share by Region (2021–2026)
Table 19. Global Colloids (Blood Plasma) Sales by Region (MT), 2027–2032
Table 20. Global Colloids (Blood Plasma) Sales Market Share by Region (2027–2032)
Table 21. Global Colloids (Blood Plasma) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021–2026)
Table 23. Global Colloids (Blood Plasma) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Colloids (Blood Plasma) Revenue Market Share by Region (2027–2032)
Table 25. North America Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 27. North America Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 28. North America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 32. Europe Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 33. Europe Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Colloids (Blood Plasma) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Colloids (Blood Plasma) Sales by Region (MT), 2021–2026
Table 37. Asia Pacific Colloids (Blood Plasma) Sales by Region (MT), 2027–2032
Table 38. Asia Pacific Colloids (Blood Plasma) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Colloids (Blood Plasma) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 42. Latin America Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 43. Latin America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 47. Middle East and Africa Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 48. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Colloids (Blood Plasma) Sales (MT) by Type (2021–2026)
Table 51. Global Colloids (Blood Plasma) Sales (MT) by Type (2027–2032)
Table 52. Global Colloids (Blood Plasma) Sales Market Share by Type (2021–2026)
Table 53. Global Colloids (Blood Plasma) Sales Market Share by Type (2027–2032)
Table 54. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021–2026)
Table 57. Global Colloids (Blood Plasma) Revenue Market Share by Type (2027–2032)
Table 58. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2021–2026)
Table 59. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2027–2032)
Table 60. Global Colloids (Blood Plasma) Sales (MT) by Application (2021–2026)
Table 61. Global Colloids (Blood Plasma) Sales (MT) by Application (2027–2032)
Table 62. Global Colloids (Blood Plasma) Sales Market Share by Application (2021–2026)
Table 63. Global Colloids (Blood Plasma) Sales Market Share by Application (2027–2032)
Table 64. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021–2026)
Table 67. Global Colloids (Blood Plasma) Revenue Market Share by Application (2027–2032)
Table 68. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2021–2026)
Table 69. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2027–2032)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 73. CSL Behring Colloids (Blood Plasma) Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 78. Baxter Colloids (Blood Plasma) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Grifols Company Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 83. Grifols Colloids (Blood Plasma) Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 88. Octapharma Colloids (Blood Plasma) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Company Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 93. Kedrion Colloids (Blood Plasma) Product
Table 94. Kedrion Recent Developments/Updates
Table 95. Shanghai Raas Company Information
Table 96. Shanghai Raas Description and Business Overview
Table 97. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 98. Shanghai Raas Colloids (Blood Plasma) Product
Table 99. Shanghai Raas Recent Developments/Updates
Table 100. CTBB Company Information
Table 101. CTBB Description and Business Overview
Table 102. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 103. CTBB Colloids (Blood Plasma) Product
Table 104. CTBB Recent Developments/Updates
Table 105. Hualan Bio Company Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 108. Hualan Bio Colloids (Blood Plasma) Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. Rongsheng Pharmaceutical Company Information
Table 111. Rongsheng Pharmaceutical Description and Business Overview
Table 112. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 113. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 114. Rongsheng Pharmaceutical Recent Developments/Updates
Table 115. Boya Rongsheng Company Information
Table 116. Boya Rongsheng Description and Business Overview
Table 117. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 118. Boya Rongsheng Colloids (Blood Plasma) Product
Table 119. Boya Rongsheng Recent Developments/Updates
Table 120. B. Braun Medical Company Information
Table 121. B. Braun Medical Description and Business Overview
Table 122. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 123. B. Braun Medical Colloids (Blood Plasma) Product
Table 124. B. Braun Medical Recent Developments/Updates
Table 125. Fresenius Kabi Company Information
Table 126. Fresenius Kabi Description and Business Overview
Table 127. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 128. Fresenius Kabi Colloids (Blood Plasma) Product
Table 129. Fresenius Kabi Recent Developments/Updates
Table 130. HOSPIRA Company Information
Table 131. HOSPIRA Description and Business Overview
Table 132. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 133. HOSPIRA Colloids (Blood Plasma) Product
Table 134. HOSPIRA Recent Developments/Updates
Table 135. Axa parenterals Company Information
Table 136. Axa parenterals Description and Business Overview
Table 137. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 138. Axa parenterals Colloids (Blood Plasma) Product
Table 139. Axa parenterals Recent Developments/Updates
Table 140. Fresenius Kabi (China) Company Information
Table 141. Fresenius Kabi (China) Description and Business Overview
Table 142. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 143. Fresenius Kabi (China) Colloids (Blood Plasma) Product
Table 144. Fresenius Kabi (China) Recent Developments/Updates
Table 145. CR Double-Crane Company Information
Table 146. CR Double-Crane Description and Business Overview
Table 147. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 148. CR Double-Crane Colloids (Blood Plasma) Product
Table 149. CR Double-Crane Recent Developments/Updates
Table 150. Kelun Group Company Information
Table 151. Kelun Group Description and Business Overview
Table 152. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 153. Kelun Group Colloids (Blood Plasma) Product
Table 154. Kelun Group Recent Developments/Updates
Table 155. Shandong Qidu Pharmaceutical Company Information
Table 156. Shandong Qidu Pharmaceutical Description and Business Overview
Table 157. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 158. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 159. Shandong Qidu Pharmaceutical Recent Developments/Updates
Table 160. Shandong Hualu Pharmaceutical Company Information
Table 161. Shandong Hualu Pharmaceutical Description and Business Overview
Table 162. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 163. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 164. Shandong Hualu Pharmaceutical Recent Developments/Updates
Table 165. Minsheng Pharma Company Information
Table 166. Minsheng Pharma Description and Business Overview
Table 167. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 168. Minsheng Pharma Colloids (Blood Plasma) Product
Table 169. Minsheng Pharma Recent Developments/Updates
Table 170. Kanglepharm Company Information
Table 171. Kanglepharm Description and Business Overview
Table 172. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 173. Kanglepharm Colloids (Blood Plasma) Product
Table 174. Kanglepharm Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Colloids (Blood Plasma) Distributors List
Table 178. Colloids (Blood Plasma) Customers List
Table 179. Colloids (Blood Plasma) Market Trends
Table 180. Colloids (Blood Plasma) Market Drivers
Table 181. Colloids (Blood Plasma) Market Challenges
Table 182. Colloids (Blood Plasma) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Colloids (Blood Plasma)
Figure 2. Global Colloids (Blood Plasma) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Colloids (Blood Plasma) Market Share by Type: 2025 & 2032
Figure 4. Natural Type Colloids (Blood Plasma) Product Picture
Figure 5. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 6. Global Colloids (Blood Plasma) Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Colloids (Blood Plasma) Market Share by Application: 2025 & 2032
Figure 8. Extensive Burns
Figure 9. Massive Blood or Plasma Loss
Figure 10. Hypovolemic Shock
Figure 11. Others
Figure 12. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Colloids (Blood Plasma) Market Size (US$ Million), 2021–2032
Figure 14. Global Colloids (Blood Plasma) Sales (MT), 2021–2032
Figure 15. Global Colloids (Blood Plasma) Average Price (USD/Kg), 2021–2032
Figure 16. Colloids (Blood Plasma) Report Years Considered
Figure 17. Colloids (Blood Plasma) Sales Share by Manufacturers in 2025
Figure 18. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Colloids (Blood Plasma) Players: Market Share by Revenue in Colloids (Blood Plasma) in 2025
Figure 20. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 23. North America Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 27. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 28. Germany Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2021–2032)
Figure 35. China Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 46. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Colloids (Blood Plasma) by Type (2021–2032)
Figure 56. Global Revenue Market Share of Colloids (Blood Plasma) by Type (2021–2032)
Figure 57. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2021–2032)
Figure 58. Global Sales Market Share of Colloids (Blood Plasma) by Application (2021–2032)
Figure 59. Global Revenue Market Share of Colloids (Blood Plasma) by Application (2021–2032)
Figure 60. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2021–2032)
Figure 61. Colloids (Blood Plasma) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Colloids (Blood Plasma) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Colloids (Blood Plasma) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Colloids (Blood Plasma) Sales (MT) of Key Manufacturers (2021–2026)
Table 5. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Colloids (Blood Plasma) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Colloids (Blood Plasma), Product Types and Applications
Table 12. Global Key Manufacturers of Colloids (Blood Plasma), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Colloids (Blood Plasma) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Colloids (Blood Plasma) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Colloids (Blood Plasma) Sales by Region (MT), 2021–2026
Table 18. Global Colloids (Blood Plasma) Sales Market Share by Region (2021–2026)
Table 19. Global Colloids (Blood Plasma) Sales by Region (MT), 2027–2032
Table 20. Global Colloids (Blood Plasma) Sales Market Share by Region (2027–2032)
Table 21. Global Colloids (Blood Plasma) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021–2026)
Table 23. Global Colloids (Blood Plasma) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Colloids (Blood Plasma) Revenue Market Share by Region (2027–2032)
Table 25. North America Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 27. North America Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 28. North America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 32. Europe Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 33. Europe Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Colloids (Blood Plasma) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Colloids (Blood Plasma) Sales by Region (MT), 2021–2026
Table 37. Asia Pacific Colloids (Blood Plasma) Sales by Region (MT), 2027–2032
Table 38. Asia Pacific Colloids (Blood Plasma) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Colloids (Blood Plasma) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 42. Latin America Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 43. Latin America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Colloids (Blood Plasma) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Colloids (Blood Plasma) Sales by Country (MT), 2021–2026
Table 47. Middle East and Africa Colloids (Blood Plasma) Sales by Country (MT), 2027–2032
Table 48. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Colloids (Blood Plasma) Sales (MT) by Type (2021–2026)
Table 51. Global Colloids (Blood Plasma) Sales (MT) by Type (2027–2032)
Table 52. Global Colloids (Blood Plasma) Sales Market Share by Type (2021–2026)
Table 53. Global Colloids (Blood Plasma) Sales Market Share by Type (2027–2032)
Table 54. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Colloids (Blood Plasma) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021–2026)
Table 57. Global Colloids (Blood Plasma) Revenue Market Share by Type (2027–2032)
Table 58. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2021–2026)
Table 59. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2027–2032)
Table 60. Global Colloids (Blood Plasma) Sales (MT) by Application (2021–2026)
Table 61. Global Colloids (Blood Plasma) Sales (MT) by Application (2027–2032)
Table 62. Global Colloids (Blood Plasma) Sales Market Share by Application (2021–2026)
Table 63. Global Colloids (Blood Plasma) Sales Market Share by Application (2027–2032)
Table 64. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Colloids (Blood Plasma) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021–2026)
Table 67. Global Colloids (Blood Plasma) Revenue Market Share by Application (2027–2032)
Table 68. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2021–2026)
Table 69. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2027–2032)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 73. CSL Behring Colloids (Blood Plasma) Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 78. Baxter Colloids (Blood Plasma) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Grifols Company Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 83. Grifols Colloids (Blood Plasma) Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 88. Octapharma Colloids (Blood Plasma) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Company Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 93. Kedrion Colloids (Blood Plasma) Product
Table 94. Kedrion Recent Developments/Updates
Table 95. Shanghai Raas Company Information
Table 96. Shanghai Raas Description and Business Overview
Table 97. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 98. Shanghai Raas Colloids (Blood Plasma) Product
Table 99. Shanghai Raas Recent Developments/Updates
Table 100. CTBB Company Information
Table 101. CTBB Description and Business Overview
Table 102. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 103. CTBB Colloids (Blood Plasma) Product
Table 104. CTBB Recent Developments/Updates
Table 105. Hualan Bio Company Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 108. Hualan Bio Colloids (Blood Plasma) Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. Rongsheng Pharmaceutical Company Information
Table 111. Rongsheng Pharmaceutical Description and Business Overview
Table 112. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 113. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 114. Rongsheng Pharmaceutical Recent Developments/Updates
Table 115. Boya Rongsheng Company Information
Table 116. Boya Rongsheng Description and Business Overview
Table 117. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 118. Boya Rongsheng Colloids (Blood Plasma) Product
Table 119. Boya Rongsheng Recent Developments/Updates
Table 120. B. Braun Medical Company Information
Table 121. B. Braun Medical Description and Business Overview
Table 122. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 123. B. Braun Medical Colloids (Blood Plasma) Product
Table 124. B. Braun Medical Recent Developments/Updates
Table 125. Fresenius Kabi Company Information
Table 126. Fresenius Kabi Description and Business Overview
Table 127. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 128. Fresenius Kabi Colloids (Blood Plasma) Product
Table 129. Fresenius Kabi Recent Developments/Updates
Table 130. HOSPIRA Company Information
Table 131. HOSPIRA Description and Business Overview
Table 132. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 133. HOSPIRA Colloids (Blood Plasma) Product
Table 134. HOSPIRA Recent Developments/Updates
Table 135. Axa parenterals Company Information
Table 136. Axa parenterals Description and Business Overview
Table 137. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 138. Axa parenterals Colloids (Blood Plasma) Product
Table 139. Axa parenterals Recent Developments/Updates
Table 140. Fresenius Kabi (China) Company Information
Table 141. Fresenius Kabi (China) Description and Business Overview
Table 142. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 143. Fresenius Kabi (China) Colloids (Blood Plasma) Product
Table 144. Fresenius Kabi (China) Recent Developments/Updates
Table 145. CR Double-Crane Company Information
Table 146. CR Double-Crane Description and Business Overview
Table 147. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 148. CR Double-Crane Colloids (Blood Plasma) Product
Table 149. CR Double-Crane Recent Developments/Updates
Table 150. Kelun Group Company Information
Table 151. Kelun Group Description and Business Overview
Table 152. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 153. Kelun Group Colloids (Blood Plasma) Product
Table 154. Kelun Group Recent Developments/Updates
Table 155. Shandong Qidu Pharmaceutical Company Information
Table 156. Shandong Qidu Pharmaceutical Description and Business Overview
Table 157. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 158. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 159. Shandong Qidu Pharmaceutical Recent Developments/Updates
Table 160. Shandong Hualu Pharmaceutical Company Information
Table 161. Shandong Hualu Pharmaceutical Description and Business Overview
Table 162. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 163. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 164. Shandong Hualu Pharmaceutical Recent Developments/Updates
Table 165. Minsheng Pharma Company Information
Table 166. Minsheng Pharma Description and Business Overview
Table 167. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 168. Minsheng Pharma Colloids (Blood Plasma) Product
Table 169. Minsheng Pharma Recent Developments/Updates
Table 170. Kanglepharm Company Information
Table 171. Kanglepharm Description and Business Overview
Table 172. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 173. Kanglepharm Colloids (Blood Plasma) Product
Table 174. Kanglepharm Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Colloids (Blood Plasma) Distributors List
Table 178. Colloids (Blood Plasma) Customers List
Table 179. Colloids (Blood Plasma) Market Trends
Table 180. Colloids (Blood Plasma) Market Drivers
Table 181. Colloids (Blood Plasma) Market Challenges
Table 182. Colloids (Blood Plasma) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Colloids (Blood Plasma)
Figure 2. Global Colloids (Blood Plasma) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Colloids (Blood Plasma) Market Share by Type: 2025 & 2032
Figure 4. Natural Type Colloids (Blood Plasma) Product Picture
Figure 5. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 6. Global Colloids (Blood Plasma) Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Colloids (Blood Plasma) Market Share by Application: 2025 & 2032
Figure 8. Extensive Burns
Figure 9. Massive Blood or Plasma Loss
Figure 10. Hypovolemic Shock
Figure 11. Others
Figure 12. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Colloids (Blood Plasma) Market Size (US$ Million), 2021–2032
Figure 14. Global Colloids (Blood Plasma) Sales (MT), 2021–2032
Figure 15. Global Colloids (Blood Plasma) Average Price (USD/Kg), 2021–2032
Figure 16. Colloids (Blood Plasma) Report Years Considered
Figure 17. Colloids (Blood Plasma) Sales Share by Manufacturers in 2025
Figure 18. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Colloids (Blood Plasma) Players: Market Share by Revenue in Colloids (Blood Plasma) in 2025
Figure 20. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 23. North America Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 27. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 28. Germany Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2021–2032)
Figure 35. China Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 46. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Colloids (Blood Plasma) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Colloids (Blood Plasma) by Type (2021–2032)
Figure 56. Global Revenue Market Share of Colloids (Blood Plasma) by Type (2021–2032)
Figure 57. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2021–2032)
Figure 58. Global Sales Market Share of Colloids (Blood Plasma) by Application (2021–2032)
Figure 59. Global Revenue Market Share of Colloids (Blood Plasma) by Application (2021–2032)
Figure 60. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2021–2032)
Figure 61. Colloids (Blood Plasma) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232